GLP-1 Receptor Agonist Use Increases Likelihood of Antidepressant Prescription

Individuals taking glucagon-like peptide (GLP)-1 receptor agonists have a greater risk for subsequently being dispensed antidepressants.

Related Keywords

Australia ,Australian ,Osvaldop Almeida , ,University Of Notre Dame ,Healthday News ,Notre Dame ,Australian Pharmaceutical Benefits Scheme ,